US Broker Ratings

Beam Therapeutics Inc. (BEAM) Stock Analysis: Unveiling a Potential 156.75% Upside in Precision Medicine

Beam Therapeutics Inc. (NASDAQ: BEAM), a biotech innovator focused on precision genetic medicines, is capturing investor attention with its significant potential upside of 156.75% based on..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a Potential 82.5% Upside for Investors

QuidelOrtho Corporation (NASDAQ: QDEL), a notable player in the healthcare sector, primarily focuses on innovative diagnostic testing solutions. Despite the company’s current challenges, its stock presents..

Organon & Co. (OGN): Investor Outlook Amid a 46% Potential Upside

Organon & Co. (OGN), a key player in the healthcare sector, particularly within the general drug manufacturing industry, presents an intriguing opportunity for investors. With a..

Belite Bio, Inc (BLTE) Stock Analysis: A 34.89% Upside Potential in the Biotech Arena

Belite Bio, Inc (NASDAQ: BLTE) is capturing the attention of investors with its promising pipeline in the biotechnology sector. Specializing in addressing unmet medical needs in..

Disc Medicine, Inc. (IRON): Investor Outlook on a Biotech Stock with 69% Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON), a promising player in the biotechnology sector, has garnered significant attention from investors and analysts alike, primarily due to its focus..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Healthcare Innovator with 23.72% Upside Potential

Alphatec Holdings, Inc. (NASDAQ: ATEC), a prominent player in the healthcare sector, is capturing investor attention with its innovative approach to spinal disorder treatments and an..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: Unpacking a 58.93% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK) is capturing the attention of investors with an impressive potential upside of 58.93%, as indicated by current analyst ratings. This..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 39% Potential Upside with Robust Revenue Growth

Veracyte, Inc. (VCYT) has become an intriguing player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $2.2 billion,..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring Over 130% Potential Upside in the Biotech Sector

Denali Therapeutics Inc. (NASDAQ: DNLI) stands as a compelling entity in the biotechnology sector, focusing intently on developing therapeutics for neurodegenerative and lysosomal storage diseases. With..

Kymera Therapeutics (KYMR) Stock Report: Biotechnology Firm Offers 60% Upside Potential

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a cutting-edge biotechnology firm headquartered in Watertown, Massachusetts, is captivating investor attention with its innovative approach to drug development and a..

Alvotech (ALVO) Stock Analysis: Exploring a Potential 105% Upside in the Biosimilars Market

Alvotech (ALVO), a dynamic player in the healthcare sector, specifically in the drug manufacturing industry for specialty and generic medications, has been capturing investor interest with..

Progyny, Inc. (PGNY) Stock Analysis: Exploring the 27.59% Potential Upside for Investors

Investors keen on healthcare opportunities may find Progyny, Inc. (NASDAQ: PGNY) an intriguing prospect in the fast-growing fertility and family-building benefits sector. With a market capitalization..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook on a Biotech Player with 18.83% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is a burgeoning name in the biotechnology sector, headquartered in Foster City, California. With a focused mission on developing novel therapies..

Xenon Pharmaceuticals (XENE) Stock Analysis: A 61% Potential Upside in Neuroscience Biotech

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian-based biopharmaceutical company, is generating buzz among investors, particularly those interested in the rapidly evolving field of neuroscience. With a..

Ascentage Pharma Group Internat (AAPG): Analyzing Growth Potential Amidst a 97.9% Revenue Surge

Ascentage Pharma Group International (AAPG) is garnering significant attention in the biotechnology sector with its impressive 97.9% revenue growth. This clinical-stage biotechnology company, headquartered in Suzhou,..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 52% Upside Potential in Biotech

Investors with a keen interest in the biotechnology sector may want to pay close attention to Vericel Corporation (NASDAQ: VCEL), a commercial-stage biopharmaceutical company that specializes..

NovoCure Limited (NVCR): Potential 149% Upside Awaits Investors in the Medical Device Innovator

As the healthcare sector continues to evolve, NovoCure Limited (NASDAQ: NVCR) stands out as a company at the forefront of medical innovation. Specializing in oncology solutions,..

Addus HomeCare Corporation (ADUS) Stock Analysis: Exploring a 23.43% Upside Potential

Addus HomeCare Corporation (NASDAQ: ADUS), a leading provider in the healthcare sector, is capturing investor attention with its strong growth potential and a significant upside in..

PTC Therapeutics, Inc. (PTCT)

⚠️ No article content returned.

..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Growth in the Dental Market with a 6.23% Potential Upside

Envista Holdings Corporation (NYSE: NVST) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Brea, California,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds